NLRP3 and metastatic malignant neoplasm in the lymph nodes: It has been shown that amplification of the NLRP3 inflammasome components was reduced in S1PR1-deficient TAMs suggesting that NLRP3 regulation in TAMs was associated with lymph node metastasis and prognosis [123].